Explore the role of MARCH E3 ubiquitin ligases as cellular regulators in cancer development and their potential as therapeutic targets.
Explore how the ubiquitin-proteasome system, the cell's protein degradation machinery, is being targeted for innovative cancer therapies like proteasome inhibitors and PROTACs.
Discover how redox-based inhibition of MGMT is overcoming chemotherapy resistance in cancer treatment through innovative biological approaches.
Explore the role of COPS6 gene in cancer progression, immune evasion, and its potential as a therapeutic target across multiple tumor types.
Discover how FBW7 protein acts as a cellular guardian by targeting SOX9 for degradation, triggering DNA damage response and S-phase arrest in cancer research.
Exploring UCHL3's paradoxical roles in cancer development and the latest research on targeted inhibitor therapies.
Explore how the CUE domain in FANCD2 protein acts as a master regulator in DNA repair and its implications for cancer prevention.
Explore how ubiquitin-dependent mechanisms control Wnt receptors in cancer development, focusing on RNF43 and ZNRF3 as key regulators in tumorigenesis.
Discover how the Otub1 enzyme stabilizes p53 through monoubiquitination, revealing a novel cancer protection mechanism
Discover how the CHD1L protein disrupts cell division, causing chromosome missegregation and driving cancer development through a novel molecular pathway.